Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Good Shroom Co Inc ( (TSE:MUSH) ).
Mercanto Holdings Inc. reported strong Q2 2026 results, with revenue more than doubling year over year to $2.08 million, gross profit rising 137%, and EBITDA and net income both turning positive. The company highlighted a clean balance sheet, noting it is current on cannabis excise taxes, has no long-term debt aside from leases, and has kept share dilution limited since going public in 2021.
Operationally, Mercanto is expanding its Québec-focused portfolio with a new 10 mg CBD capsule format slated for in-store launch in August 2026, complementing its higher-dose CBD capsules and broadening its reach across different consumer segments. The company also plans to have a full four-SKU CBD capsule lineup available online and will add an infused pre-roll offering in June 2026, positioning itself to capture growth in one of Québec’s faster-growing derivative categories and potentially strengthen its competitive standing in the province’s cannabis market.
The most recent analyst rating on (TSE:MUSH) stock is a Hold with a C$0.14 price target. To see the full list of analyst forecasts on Good Shroom Co Inc stock, see the TSE:MUSH Stock Forecast page.
Spark’s Take on MUSH Stock
According to Spark, TipRanks’ AI Analyst, MUSH is a Neutral.
The score is held back primarily by weak profitability and pressured equity despite strong revenue growth and improved (but potentially volatile) cash flow. Technicals provide meaningful support due to a clear uptrend and positive momentum, while valuation remains constrained by negative earnings and no dividend.
To see Spark’s full report on MUSH stock, click here.
More about Good Shroom Co Inc
Mercanto Holdings Inc. is a Montréal-based cannabis company focused on the Québec market, where it develops, launches and commercializes cannabis products in categories it believes can support differentiated positioning and profitable growth. The company emphasizes targeted product development across CBD capsules and infused derivatives to build share in key provincial segments.
Average Trading Volume: 24,410
Technical Sentiment Signal: Buy
Current Market Cap: C$6.98M
See more data about MUSH stock on TipRanks’ Stock Analysis page.